Need for caution when interpreting Xpert® MTB/RIF results for rifampin resistance among children.

Saved in:
Bibliographic Details
Title: Need for caution when interpreting Xpert® MTB/RIF results for rifampin resistance among children.
Authors: Murithi W; Center for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya., Click ES; U.S. Centers for Disease Control and Prevention (CDC), Atlanta, GA USA., McCarthy KD; CDC, Kisumu, Kenya., Okeyo E; Center for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya., Sitati R; Center for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya., Anyango I; Center for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya., Okumu A; Center for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya., Mchembere W; Center for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya., Song R; Division of Infectious Diseases, Boston Children´s Hospital, Boston, MA, Department of Pediatrics, Harvard Medical School, Boston, MA, USA, Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Cain K; CDC, Kisumu, Kenya.
Source: The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease [Int J Tuberc Lung Dis] 2021 Nov 01; Vol. 25 (11), pp. 911-916.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
Journal Info: Publisher: International Union against Tuberculosis and Lung Disease Country of Publication: France NLM ID: 9706389 Publication Model: Print Cited Medium: Internet ISSN: 1815-7920 (Electronic) Linking ISSN: 10273719 NLM ISO Abbreviation: Int J Tuberc Lung Dis Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1815-7920
DOI:10.5588/ijtld.21.0126